Clene Inc Stock Today
Clene is selling for under 0.0397 as of the 17th of March 2025; that is 32.33 percent increase since the beginning of the trading day. The stock's lowest day price was 0.03. The performance scores are derived for the period starting the 17th of December 2024 and ending today, the 17th of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 31st of December 2020 | Category Consumer Defensive | Classification Health Care |
Valuation Profit Patterns
Check how we calculate scores
Clene Stock Highlights
| President CEO | Robert MBA | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Consumer Defensive, Health Care, Biotechnology, Materials, Materials (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Clene can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Clene's financial leverage. It provides some insight into what part of Clene's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Clene Inc (CLNNW) is traded on NASDAQ Exchange in USA. It is located in 6550 South Millrock Drive, Salt Lake City, UT, United States, 84121 and employs 82 people. Clene is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 646.98 M. Clene Inc classifies itself under Biotechnology sector and is part of Health Care industry.
Clene Inc has accumulated about 36.78 M in cash with (30.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.29, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Clene Probability Of Bankruptcy
Clene Historical Income Statement
Clene Stock Against Markets
Clene Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Clene stock to make a market-neutral strategy. Peer analysis of Clene could also be used in its relative valuation, which is a method of valuing Clene by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Clene Corporate Management
| Robert MD | Chief Officer | Profile | |
| Jeong Ted | Chief Officer | Profile | |
| Mark ESQ | Chief Officer | Profile | |
| Michael Hotchkin | Chief Officer | Profile | |
| Rob Etherington | Pres CEO | Profile | |
| Mark Mortenson | CoFounder Officer | Profile |
Additional Tools for Clene Stock Analysis
When running Clene's price analysis, check to measure Clene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clene is operating at the current time. Most of Clene's value examination focuses on studying past and present price action to predict the probability of Clene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clene's price. Additionally, you may evaluate how the addition of Clene to your portfolios can decrease your overall portfolio volatility.